Home > Healthcare > Biotechnology > Biotechnology R&D > Fetal Bovine Serum Market

Fetal Bovine Serum Market Size

Report ID: GMI6517
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Fetal Bovine Serum Market Size

Fetal Bovine Serum Market size was valued to be USD 1.1 billion in 2022 and is expected to reach USD 2.5 billion in 2032 with a CAGR of 8.1% till 2032 driven by the expanding scope of research and development within the pharmaceutical and biotechnological sectors.

To get key market trends

Download Free Sample

This expansion is paralleled by the increasing occurrence of chronic diseases, where the utilization of fetal bovine serum in both diagnosis and treatment has gained notable prominence. Also, fetal bovine serum, due to its rich nutrient composition, is notably integrated into cell culture processes, aiding cell growth and fostering research endeavors. This symbiotic relationship between research demands and disease prevalence has led to a notable industry upswing in the usage of fetal bovine serum within these critical industries. Moreover, high demand of sera in among end-users including academic institutes for drug development and cell culture media.

Fetal Bovine Serum Market Report Attributes
Report Attribute	Details
Base Year:	2022
Fetal Bovine Serum Market Size in 2022:	USD 1.1 Billion
Forecast Period:	2023 to 2032
Forecast Period 2023 to 2032 CAGR:	8.1%
2032 Value Projection:	USD 2.5 Billion
Historical Data for:	2018 to 2022
No. of Pages:	126
Tables, Charts & Figures:	212
Segments covered:	Product type, Application, End-user and Region
Growth Drivers:	Increasing research activities in biopharmaceutical and biotechnological field High demand for fetal bovine sera Increasing prevalence of acute and chronic diseases
Pitfalls & Challenges:	Ethical and scientific concerns associated with collection of fetal bovine serum Availability of the alternatives in the market

Learn more about the key segments shaping this market

Download Free Sample

Fetal bovine serum, also known as fetal calf serum, is a blood-derived product obtained from the blood of fetal bovine (cow) foetuses. It is rich in various growth factors, hormones, and other nutrients, making it an ideal supplement to promote the progress and proliferation of many types of animal cells.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Fetal bovine serum market size reached USD 1.1 billion in 2022 and will witness 8.1% CAGR through 2032 due to the expanding scope of research and development within the pharmaceutical and biotechnological sectors worldwide.

The stem cell segment registered 30.4% share in 2022 and will witness substantial growth by 2032 on account of its remarkable potential in various scientific and medical applications.

North America industry will record 38.3% share in 2022 and is expected to garner significant CAGR from 2023-2032 owing to the presence of prominent players and better governing policies in the region.

Thermo Fisher Scientific, Inc., Danaher Corporation, Atlas Biologicals, Inc., Bio-Techne, Himedia Laboratories Pvt Ltd, Merk KGaA, Pan-biotech, Sera Scandia A/S (Biowest), Rocky Mountain Biologicals (RMBIO) are some of the major fetal bovine serum companies worldwide.